Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 27, 2020 08:30 ET | Source: Corium International, Inc.

Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease

MENLO PARK, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Corium, Inc., a commercial-stage biopharmaceutical company leading the development of novel transdermal healthcare products that are intended to...
April 02, 2019 16:30 ET | Source: Corium International, Inc.

Corium Appoints Perry Sternberg as Chief Executive Officer

MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Corium, Inc. announced today that its Board of Directors has named Perry Sternberg as Chief Executive Officer. Mr. Sternberg is a senior...
December 17, 2018 09:30 ET | Source: Corium International, Inc.

Corium Announces Offer to Purchase for Cash Any and All of the $120,000,000 Aggregate Outstanding Principal Amount of 5.00% Convertible Senior Notes due 2025

MENLO PARK, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc., a Delaware corporation (“Corium”, the “Issuer”, “we”, “us” or “our”), today announced that, as a result of its...
October 11, 2018 16:03 ET | Source: Corium International, Inc.

Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares

Total Transaction Valued in Excess of $500 Million, Representing a 50% Premium Gurnet Point Capital to Expand Operations While Focusing on the Approval and Commercialization of Corium’s Corplex...
September 24, 2018 07:30 ET | Source: Corium International, Inc.

Corium to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference

MENLO PARK, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
August 29, 2018 07:30 ET | Source: Corium International, Inc.

Corium to Present at the H. C. Wainwright 20th Annual Global Investment Conference

MENLO PARK, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
August 09, 2018 16:01 ET | Source: Corium International, Inc.

Corium Reports Third Quarter Fiscal 2018 Financial Results and Corporate Highlights

MENLO PARK, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
August 02, 2018 07:30 ET | Source: Corium International, Inc.

Corium to Report Third Quarter Fiscal 2018 Financial Results on Thursday, August 9, 2018

MENLO PARK, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ: CORI) today announced that it will report financial results for the third quarter ended June 30, 2018 on...
July 25, 2018 10:30 ET | Source: Corium International, Inc.

Corium Presents Additional Positive Clinical Results at Alzheimer's Association International Conference® 2018

MENLO PARK, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
July 11, 2018 07:30 ET | Source: Corium International, Inc.

Corium Announces Issuance of Additional U.S. Patent Covering Corplex™ Donepezil Transdermal System for Alzheimer’s Disease

MENLO PARK, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI), a commercial stage biopharmaceutical company focused on the development, manufacture and...